Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefotaxime-tazobactam vs cefotaxime-sulbactam in acute lower respiratory and urinary tract infections
CTR20150297Phase 2Completed
- Sponsor
- C&O Pharmaceutical Technology (Holdings) Limited
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefotaxime + tazobactam in Acute bacterial lower respiratory tract infection (ABLRTI), Acute Bacterial Urinary Tract Infection (UTI), sponsored by C&O Pharmaceutical Technology (Holdings) Limited. Started May 2015; status: completed.
02
Drugs
cefotaxime + tazobactam
03
Conditions
Acute bacterial lower respiratory tract infection (ABLRTI)Acute Bacterial Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20150297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150297.